Medical Products and Support Systems Development
Abstract
This Program Element (PE) funds system development and demonstration of medical commodities delivered from the various medical advanced development and prototyping DoD Components that are directed at meeting validated requirements prior to full-rate initial production and fielding, including initial operational test and evaluation and clinical trials. These clinical trials are conducted to obtain US Food and Drug Administration (FDA) approval, a requirement for use of all medical products. Research in this PE is designed to address the following: areas of interest to the Secretary of Defense regarding Wounded Warriors, capabilities identified through the Joint Capabilities Integration and Development System, and the strategy and initiatives described in the Quadrennial Defense Review. Program development and execution is peer-reviewed and fully coordinated with all of the Military Services, appropriate Defense Agencies or Activities and other federal agencies, to include the Department of Veterans Affairs, the Department of Health and Human Services, and Department of Homeland Security. This coordination occurs through the planning and execution activities of the Joint Program Committees, established for the Defense Health Program Research, Development, Test and Evaluation funding. The work includes development and demonstration of medical modeling and simulation systems for training/education/treatment, and medical system development and demonstration. The funding also supports the clinical evaluation of hyperbaric oxygenation for post-concussion syndrome (PCS). The effort encompasses development, initiation, operation, analysis, and subsequent publication of clinical trials to compare and assess the long-term benefit of hyperbaric oxygen (HBO2) therapy on service members with (PCS). As the research efforts mature, the most promising will transition to production and deployment or to industry.
Document Details
- Document Type
- R2 Budgetary Justification
- Publication Date
- Oct 01, 2015
- Source ID
- 0605145HP_2_0130_PB_2015
- Change Summary Explanation
- FY 2013: Realignment from Defense Health Program, Research, Development, Test and Evaluation (DHP RDT&E), PE 0605145-Medical Products and Support Systems Development (-$2.889 million) to DHP RDT&E PE 0605502-Small Business Innovation Research (SBIR) Program (+$2.889 million). FY 2013: General Congressional Reductions to DHP RDT&E, PE 0605145-Medical Products and Support Systems Development (-$0.023 million). FY 2013: Congressional Directed Reductions (Sequestration) to DHP RDT&E, PE 0605145-Medical Products and Support Systems Development (-$4.964 million). FY 2014: Realignment from Defense Health Program, Research, Development, Test and Evaluation (DHP RDT&E), PE 0605145-Medical Products and Support Systems Development (-$0.531 million) to DHP RDT&E PE 0605502-Small Business Innovation Research (SBIR) Program (+$0.531 million). FY 2015: Reduces non-combat injury research funding in order to focus and continue the pace of progress in critical and high priority research areas for DHP RDT&E, PE 0605145-Medical Products and Support Systems Development (-$11.356 million).
- Service Agency Name
- Defense Health Program
Related Documents
- Child Project: GDF-Medical Products and Support System Development
- Child Accomplishment: GDF - Medical Products and Support Systems Development (GDF-MPSSD)
- Child Project: Hyperbaric Oxygen Therapy Clinical Trial (Army)
- Child Accomplishment: Hyperbaric Oxygen Therapy Clinical Trial (Army)